Brookline Capital Markets initiated coverage of Medicus Pharma (NASDAQ:MDCX) with a buy rating, citing the potential of its ...

Medicus Pharma Ltd (MDCX) has received a new Buy rating, initiated by Brookline Capital Markets analyst, Kumaraguru Raja.Don't Miss Our ...

UPDATE: I’ll save you the gory pics, but they cut into my nose twice to get all of the basal cell and it turned out... Posted ...

Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory of Advanced Negative Carbon Technologies, Soochow University, Suzhou 215123, China ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International ...

The Department of Cell and Molecular Biology at Karolinska Institutet is a nationally leading academic research center of high international standard where science comes first and foremost. CMB ...

My heart sinks. This would be the third basal cell carcinoma (BCC) I have had removed from my face in a matter of months. Two on my nose and one on my forehead. The MOHS surgery took place at ...

US doctors say they have successfully carried out surgery on babies in the womb to repair harmful spine defects using a special, therapeutic stem cell patch method. Experts hope the pioneering ...